NEW YORK (GenomeWeb News) – Hologic reported after the close of the market Monday that its fourth-quarter 2012 revenues climbed 26 percent year over year with a large chunk of that increase due to Gen-Probe's sales contribution.

The Bedford, Mass.-based diagnostics, medical imaging, and surgical products firm reported total revenues of $588.5 million for the three months ended Sept. 29, up from $467.0 million for the fourth quarter of 2011. It beat the consensus Wall Street estimate of $581.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.